fbpx

HOUSTON, Sept. 13, 2022 /PRNewswire/ -- Last month the Houston Business Journal announced DECISIO Health as a recipient of the Innovation Awards. The award honors Houston's most innovative companies at the fourth annual Innovation Awards. More than just a startup/tech awards program, Houston Business Journal recognizes innovation across all industries and all facets of business. The evaluation criteria ensures that all companies, regardless of industry, domain or innovation type can clearly communicate, affirm and support their nomination. DECISIO Health will be featured in a special section of the Houston Business Journal's September 23rd weekly edition. DECISIO recently gained a patent related to a computer program product providing a novel patient dashboard system in a hospital setting. The flagship product, InsightIQ™, reduces clinical variation, improves outcomes while decreasing costs with digitized bundles of care that prioritizes clinicians' attention to at-risk patients requiring early intervention.  "We are excited and honored to receive this award. We feel this reflects the passion our company has for improving patients' outcomes and our customers' confidence in our products." said Co-CEO Dr. John Holcomb. About DECISIO ® DECISIO is a Houston-based digital health company with a customizable clinical decision support platform designed to aggregate and prioritize near real-time data, from any device, and present it visually in one place. The...

In medicine, every second counts. A patient can be stable one minute and crash during the next moment. Early detection, timeliness, and competency of clinical response are a triad of determinants that impact clinical outcomes of people with acute illness. Results from observational studies confirm that patients often show signs of clinical deterioration during the 24 hours before a severe event requiring clinical intervention.1  Timely detection of those subtle clinical warning signs has its own set of challenges. When those clinical values (especially vital signs) cross a critical threshold, they usually alert the bedside staff via beeping monitors. Because of the volume of alerts and the mountain of tasks that bedside staff manage, many alarms are simply silenced in seemingly stable patients. Thus, a critical value is often lost and not documented in the EMR system. Documentation of an alert is another task that can be triaged and forgotten. In some cases, especially in non-critical care settings, critical (outlier/severe) values may not trigger an alert, or the vital signs may not be taken as frequently.  Automated capture of vital signs and real-time alerts could reduce the burden on bedside staff while increasing data capture. However, the intense amount and frequency of data...

You may have heard of the term failure to rescue or the abbreviation FTR when discussing patient outcomes. Traditionally, FTR is defined as unexpected deterioration of a patient or death due to a complication. The complication could be due to an underlying illness or related to medical care. Both hospitals and physicians recognize FTR as an urgent problem with numerous and multifaceted contributing factors. A patient’s poor outcome due to FTR could be related to any of the following challenges:  Inadequate or inconsistent method of collecting vital signs data  Failure to recognize and respond rapidly to abnormal vital signs Delays in timely escalation of care for patients showing signs of clinical deterioration  Many hospitals manually collect vital signs, where data is entered by a health care professional into the patient's electronic health record (EHR) every 4 to 12 hours. This approach represents single data points in time but does not reflect what happens during time intervals between data captures. During these undocumented intervals, patients may rapidly or subtly deteriorate. By the time clinicians become aware of this decline, the complication may be full blown and lead to an FTR episode. How can a health care organization reduce the number of FTR cases? 1. Automate the Capture...

While preventing all medication complications is impossible, health care providers strive to identify the risks of complications for their patients.  Complications can increase a patient’s length of stay, consume limited staff resources, increase the need for higher levels of care, and even lead to the patient's death. When a patient unexpectedly deteriorates from a complication, the poor outcome is often referred to as a failure to rescue or FTR case. The term can be used as a diagnosis or as a safety and quality measure. Hospital records use a coding system that can identify the diagnosis for a patient, and FTR has such a code. Since 2003, many healthcare organizations review their records to identify the underlying causes of their FTR cases to improve patient care and outcomes. In 2010, the Centers for Medicare and Medicaid Services began to monitor FTR rates using an algorithm called Patient Safety Indicators 04 (PSI 04). With the advancement of the electronic medical record, data collection and analysis in the field of FTR has exploded. A few of the key studies and findings are highlighted below: Approximately 10% of general ward patients experience unexpected decompensation, with half transferred to an intensive care unit (ICU).1 Over 85% of cardiac...

Critical Care Medicine is the medical specialty of caring for patients with immediate life-threatening conditions. These types of patients need frequent assessment and have a greater need for technological support than other patients admitted to the hospital. Hence, the specialty involves the assessment and management of these critical patients in specialized units of the hospital. As with most of the medical specialties, critical care medicine has humble origins with the development of “Iron Lung” technology during the polio epidemic in the 1950s. In the earlier days of the specialty, any physician could render Critical Care. As this area of medicine became more sophisticated - involving advanced technologies and clinical skills, specialized nursing units in the 1960s called Intensive Care Units (ICUs) were developed to care for the critically ill patients. On the training side, formalized pathways to certification, in the knowledge base and skills to care for these patients, were developed through the American Association of Critical Care Nurses. Eventually, the established medical specialties of Internal Medicine, Surgery, Anesthesiology, Emergency Medicine, and Neurology created a formal training curriculum and certification in the subspecialty of Critical Care Medicine.  ICUs and Critical Care Medicine, along with Emergency Medicine, have become the safety net of...

HOUSTON, TX, May 8, 2022 – DECISIO announced yesterday the issuance of US Patent 11,309,079 B2, which related to a system, method, and computer program product for providing a patient dashboard system in a hospital setting.  The patent covers a method of displaying information in a patient care setting using a near real-time monitoring dashboard. It further covers the collection and aggregation of clinical information from multiple sources to interpret and display actionable insight. Patent 11,309,079 B2, titled, ‘System And Method For A Patient Dashboard’, filters, analyzes, and displays patient data that is relevant to the treatment of the patient, including recommended medical actions and pertinent positives and negatives results. The company recently rebranded DECISIO and launched a new website. The flagship product, previously DECISIOInsight, is now named InsightIQTM. InsightIQ reduces clinical variation with digitized bundles of care that prioritizes clinicians’ attention to at-risk, deteriorating patients for early intervention.  EnvisionIQTM, a clinical analytics platform, was announced in early 2022 and paves the way for a whole suite of DECISIO IQ products to be announced in the near future.  “The changes we have made at DECISIO over the course of the past several months only strengthens the confidence we have in the huge potential...

Houston-based Decisio Health wants to expand its platform to more hospital systems using new funding. The health technology firm recently closed a Series B fundraising round at $18.5 million, bringing Decisio's total funds raised to $31.5 million to date. David Moxam, executive chairman at Decisio, said the majority of the firm's existing stakeholders reinvested in Decisio's latest fundraising round. Using proceeds from the fundraising round, Decisio aims to roll out its real­ time patient monitoring platform with more large health care systems, Moxam said. Read the full article in the Houston Business Journal: https://www.bizjournals.com/houston/news/2022/04/11/decisio-health-patient-monitor-tech-fundraising.html ...

HOUSTON, TX, March 8, 2022 – DECISIO®, a company creating customizable clinical decision support tools to present real-time data across adaptable interfaces, has added a new product named EnvisionIQ™. This solution offers templated real-time and customized compliance reports to improve operational efficiency.  EnvisionIQ is a hospital’s solution to visualize critical patient outcome datasets across all bundles of care and service lines in real-time. The proprietary product helps hospitals unlock clinical data at the minutiae level in order to identify meaningful process change and work-flow improvements, leading to a reduction in complications, readmission rates.  EnvisionIQ enables a health system to benchmark their clinicians, units, and hospitals to accelerate improvements, reduce variation, and expedite data collection for agency reporting requirements.     “Clinical benchmarking tools are essential to enable health systems to quickly identify improvement opportunities that have substantial impact. The addition of EnvisionIQ to our product portfolio allows DECISIO to provide comprehensive surveillance and analytics platforms to benefit hospitals in many capacities,” said Paul Sinclair, Chief Revenue Officer at DECISIO.    EnvisionIQ provides insights into current care patterns, protocol compliance, areas for workflow improvement, and analysis of clinical datasets.  It works across various diagnosis and care bundles, including Ventilator, Stroke, and Sepsis Management, plus many more. The...

Decisio Health believes that now, more than ever,  our technology, which is a decision support device indicated for aggregating, displaying and managing physiological and other patient information, is an important part of helping to deliver the best care to COVID-19 patients during this pandemic when hospitals are at their busiest.  As a company, we are providing support to the University of Arkansas for Medical Sciences (UAMS) by assisting with their most urgent clinical needs through innovation. Our partnership is making an impact through monitoring of critical patients and their response to therapy, expanded patient surveillance, and supporting COVID-19 research. UAMS has treated over 800 COVID-19 patients to date and while the pandemic continues to disrupt the world we live in, their infection prevention and dedicated hospitalist teams are working tirelessly to treat this unique group of patients. It is no surprise that this pandemic is a constant stressor to those on the front lines and we aim to lessen the burden on clinicians by extending the capability of our software to help them care for patients during these exhausting times. Our robust monitoring and data visualization provides increased patient awareness for potentially faster decision making in each intensive care unit at...

GE Healthcare today announced its investments in and collaborations with Formlabs, CMR Surgical Ltd. and Decisio Health, companies specializing in 3D printing, surgical robotics and virtual care monitoring respectively. When paired with GE Healthcare’s diagnostic expertise and global scale, these three novel healthcare technologies will help expand clinical capabilities and enable more effective diagnosis, treatment and monitoring of patients. “Healthcare’s next chapter will be written in part by emerging technologies like 3D printing, robotic surgery and virtual patient monitoring,” said Kieran Murphy, president and CEO of GE Healthcare. “That’s why we’re putting GE Healthcare’s innovative engine and resources behind collaborations with these exciting, next generation companies – to help change the way clinicians work and enable more precise patient care.” 1. GE Healthcare is collaborating with Formlabs, a Massachusetts-based manufacturer of advanced, affordable 3D-printers that can help clinicians easily and quickly print anatomical models at the point of care. These tangible models accurately visualize patient anatomy and disease for improved communication within the medical team, better hands-on case-based teaching models and enhanced patient education. Radiologists can use GE Healthcare’s Advantage Workstation to prepare 3D CT or MRI data to assist in diagnosis and procedure planning, then export using 3D Suite in a...